Legal & General Group’s Fennec Pharmaceuticals FENC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$67.4K Buy
8,128
+5,677
+232% +$47K ﹤0.01% 2677
2025
Q1
$15K Hold
2,451
﹤0.01% 3049
2024
Q4
$15.5K Hold
2,451
﹤0.01% 3117
2024
Q3
$12.3K Hold
2,451
﹤0.01% 3234
2024
Q2
$15.1K Buy
2,451
+748
+44% +$4.6K ﹤0.01% 3141
2024
Q1
$18.9K Hold
1,703
﹤0.01% 2987
2023
Q4
$19.1K Buy
1,703
+209
+14% +$2.34K ﹤0.01% 3047
2023
Q3
$11.2K Sell
1,494
-444
-23% -$3.33K ﹤0.01% 3245
2023
Q2
$17.1K Buy
+1,938
New +$17.1K ﹤0.01% 3178
2021
Q2
Sell
-2,473
Closed -$15K 3546
2021
Q1
$15K Sell
2,473
-243
-9% -$1.47K ﹤0.01% 3243
2020
Q4
$20K Hold
2,716
﹤0.01% 3087
2020
Q3
$16K Sell
2,716
-841
-24% -$4.95K ﹤0.01% 3042
2020
Q2
$30K Buy
+3,557
New +$30K ﹤0.01% 2891
2019
Q3
Sell
-1,681
Closed -$7K 3376
2019
Q2
$7K Hold
1,681
﹤0.01% 3416
2019
Q1
$8K Hold
1,681
﹤0.01% 3275
2018
Q4
$11K Hold
1,681
﹤0.01% 3253
2018
Q3
$14K Hold
1,681
﹤0.01% 3279
2018
Q2
$18K Buy
+1,681
New +$18K ﹤0.01% 3210